Skip to main content
ALLURION TECHNOLOGIES, INC. logo

ALLURION TECHNOLOGIES, INC. — Investor Relations & Filings

Ticker · ALUR ISIN · US02008G1022 US Human health and social work activities
Filings indexed 303 across all filing types
Latest filing 2025-05-20 Interim / Quarterly Rep…
Country US United States of America
Listing US ALUR

About ALLURION TECHNOLOGIES, INC.

https://www.allurion.com/en

Allurion Technologies, Inc. is a company focused on ending obesity through its comprehensive weight-loss platform, the Allurion Program. The program's core component is a procedure-less, swallowable gastric balloon that is placed during an outpatient visit and passes naturally after approximately four months. This device is integrated into a full-stack solution that includes a digital ecosystem for real-time progress tracking via connected devices, an AI-powered coaching assistant, and personalized support from a multidisciplinary team of healthcare professionals. The platform is designed to promote sustainable, metabolically healthy weight loss by combining appetite regulation with behavioral change support. It can function as a standalone treatment or in combination with other therapies, including the company's AI-native compounded GLP-1 program.

Recent filings

Filing Released Lang Actions
424B3
Interim / Quarterly Report Classification · 100% confidence The document is a Form 10-Q Quarterly Report filed with the SEC for the quarterly period ended March 31, 2025. It includes detailed financial statements, management's discussion and analysis, risk factors, legal proceedings, and other substantive financial and operational information. The document is lengthy (15,000 characters) and contains actual financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2025-05-20 English
10-Q
Interim / Quarterly Report Q1 2025
2025-05-15 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-05-15 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated May 14, 2025. It announces the issuance of a press release containing financial results for the quarter ended March 31, 2025. The text explicitly states that the press release is attached as Exhibit 99.1 and is incorporated by reference. The document itself does not contain detailed financial statements or substantive financial data but rather serves as a notification of the earnings release. The length of the document is 3851 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, such a document announcing the earnings release but not containing the full financial data should be classified as an Earnings Release (ER).
2025-05-14 English
Regulatory Filings 2025
Regulatory Filings
2025-05-12 English
Regulatory Filings 2025
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of the effective date for a Registration Statement on Form S-3. It is a formal correspondence related to a regulatory filing process rather than a financial report or detailed disclosure document. The content is short (1477 characters) and does not contain financial data or report content. It is an announcement/request related to a regulatory filing process, fitting the category of Regulatory Filings (RNS).
2025-05-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.